SCHEMBL14923600

SCHEMBL14923600

CC(C)C[C@@H](CN1C(=O)c2ccccc2C1=O)Nc1nc(Cl)c(C#N)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ PGK1 P00558 1/20 0.36
▸ KHK P50053 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ACHE P22303 3/20 0.34
▸ BCHE P06276 2/20 0.34
▸ GAA P10253 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ MDM2 Q00987 1/20 0.33
▸ ALOX5AP P20292 2/20 0.33
▸ FEN1 P39748 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14923606 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL14923707 0.89 PGK1 (0.38) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL14911299 0.88 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL14911298 0.88 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL14923516 0.87 PGK1 (0.37) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL3345311 0.87 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL16165769 0.86 ACHE (0.40) ALDH1A1SMN1; SMN2PGK1KHKCYP1A2
SCHEMBL15081454 0.86 ACHE (0.40) ALDH1A1SMN1; SMN2PGK1KHKCYP1A2
SCHEMBL14911213 0.86 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL14911214 0.86 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK ALDH1A1 1638/4885SMN1; SMN2 2190/4885HPGD 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback